HALEOS LABS DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.71×	0.71×	0.72×	0.64×	0.69×
	0.86×	0.86×	0.87×	0.61×	0.92×
	7.7%	8.8%	8.7%	5.3%	5.7%
	0.79×	0.79×	0.88×	0.78×	0.84×
	1.98×	1.98×	1.84×	2.02×	2.10×
	7.4%	8.3%	8.8%	3.3%	6.4%
	8.4%	8.4%	10.8%	5.3%	7.2%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

HALEOSLABS₹1,429.20

HALEOS LABS LIMITED

· Pharma & Health

₹ CrorePeersALBERTDAVD VALIANTLAB MEDICO MEDICAMEQ ZIMLAB AAREYDRUGS NECLIFE ANUHPHRMcap ₹432 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.69	0.64	0.72	0.71	0.71
Interest Burden (Pretax/EBIT) ×	0.92	0.61	0.87	0.86	0.86
EBIT Margin %	5.69	5.29	8.71	8.75	7.71
Asset Turnover ×	0.84	0.78	0.88	0.79	0.79
Financial Leverage (Assets/Equity) ×	2.10	2.02	1.84	1.98	1.98
ROE (5-step product, year-end total equity) %	6.35	3.25	8.79	8.34	7.36
ROE (owners' profit / average owners' equity) %	7.15	5.26	10.77	8.44	8.44

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.